The safety of covid-19 vaccinations—we should rethink the policy
H Walach, RJ Klement, W Aukema - Vaccines, 2021 - mdpi.com
Background: COVID-19 vaccines have had expedited reviews without sufficient safety data.
We wanted to compare risks and benefits. Method: We calculated the number needed to …
We wanted to compare risks and benefits. Method: We calculated the number needed to …
COVID-19 and vaccination: myths vs science
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
Is a COVID-19 vaccine likely to make things worse?
SMC Abo, SR Smith? - Vaccines, 2020 - mdpi.com
In order to limit the disease burden and economic costs associated with the COVID-19
pandemic, it is important to understand how effective and widely distributed a vaccine must …
pandemic, it is important to understand how effective and widely distributed a vaccine must …
[引用][C] US public now divided over whether to get COVID-19 vaccine
A Tyson, C Johnson, C Funk - 2020 - policycommons.net
US Public Now Divided Over Whether To Get COVID-19 Vaccine | Policy Commons Skip to
main content Policy Commons Open menu Search Advanced Help Register Login …
main content Policy Commons Open menu Search Advanced Help Register Login …
[HTML][HTML] “When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination
BR Bloom, GJ Nowak, W Orenstein - New England Journal of …, 2020 - Mass Medical Soc
“When Will We Have a Vaccine?” People inquiring about Covid-19 vaccines often want to
know when the public can be confident that available vaccines are safe and effective, when …
know when the public can be confident that available vaccines are safe and effective, when …
Adverse events following COVID-19 vaccination: A systematic review and meta-analysis
H Kouhpayeh, H Ansari - International Immunopharmacology, 2022 - Elsevier
Background High speed of COVID-19 vaccination has raised some concerns about the
safety of the new vaccines. It is of a great importance to perform a review of the safety and …
safety of the new vaccines. It is of a great importance to perform a review of the safety and …
Lifting non-pharmaceutical interventions following the COVID-19 pandemic–the quiet before the storm?
KB Oh, TM Doherty, V Vetter… - Expert review of vaccines, 2022 - Taylor & Francis
Introduction In the first months of the novel coronavirus (COVID-19) pandemic that begun in
2020, non-pharmaceutical interventions (NPIs) have been adopted worldwide. However, the …
2020, non-pharmaceutical interventions (NPIs) have been adopted worldwide. However, the …
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations
J Sultana, G Mazzaglia, N Luxi… - Expert review of …, 2020 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease (COVID-19), caused by severe acute
respiratory syndrome coronavirus (SARS-CoV-2), has quickly spread around the world …
respiratory syndrome coronavirus (SARS-CoV-2), has quickly spread around the world …
COVID-19 vaccine boosters: the good, the bad, and the ugly
Pursuing vaccinations against COVID-19 brings hope to limit the spread of SARS-CoV-2
and remains the most rational decision under pandemic conditions. However, it does not …
and remains the most rational decision under pandemic conditions. However, it does not …
Impact of COVID-19 on vaccination programs: adverse or positive?
I Ali - Human vaccines & immunotherapeutics, 2020 - Taylor & Francis
The COVID-19 pandemic has posed multiple substantial challenges, affecting not only
public health but also economic systems, socio-cultural patterns, and political institutions …
public health but also economic systems, socio-cultural patterns, and political institutions …